Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience

For recipients of allogeneic hematopoietic stem cell transplant (HSCT), mycophenolate mofetil (MMF) plus tacrolimus combination is mostly used in reduced-intensity (RIC), and nonmyeloablative conditioning (NMAC) whereas methotrexate and tacrolimus combination is preferred in myeloablative conditioni...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashmi, Hamza, Bhandari, Shruti, Dhanoa, Jugraj, Wu, Xiaoyong, Rai, Shesh, Figg, Lindsay, Baize, Timothy, Krem, Maxwell, Hegazi, Mohamed, Emmons, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058400/
https://www.ncbi.nlm.nih.gov/pubmed/32190456
http://dx.doi.org/10.7759/cureus.6893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058400/
https://www.ncbi.nlm.nih.gov/pubmed/32190456
http://dx.doi.org/10.7759/cureus.6893

Ejemplares similares